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The nicotinamide coenzyme NADH, consumed in enantiose-
lective reduction of ketones catalysed by alcohol dehydroge-
nases, needs to be regenerated in order to maintain enzy-
matic activity. We therefore studied the catalytic potential of
the cationic complexes [(η5-C5Me5)Rh(NN)Cl]+ (1: NN =
1,10-phenanthroline; 2: NN = 5-nitro-1,10-phenanthroline;
3: NN = 5-amino-1,10-phenanthroline), [(η5-C5Me5)
Ir(NN)Cl]+ (4: NN = 5-nitro-1,10-phenanthroline) and
[(η6-C6Me6)Ru(NN)Cl]+ (5: NN = 5-nitro-1,10-phenan-
throline), isolated as the water-soluble chloride salts, for
transfer hydrogenation of NAD+ to give NADH in aqueous
solution. The best results were obtained with rhodium com-
plex 1, which gave catalytic turnover frequencies up to
2000 h–1 in aqueous solution at pH 7 and 60 °C with sodium
Introduction
There is an increasing demand for enantiopure biolo-
gically active compounds and their precursors.[1] The transi-
tion-metal-based enantioselective hydrogenation or transfer
hydrogenation of ketones in organic solvents[2–10] as well as
in aqueous solutions[11–21] is one of the most commonly
used synthetic approaches. Biotransformations of organic
substrates by various enzymes have also found widespread
applications, particularly because of their capability to ef-
ficiently perform enantioselective transformations. The use
of redox enzymes for synthetic purposes, however, has been
limited by the need of cofactor regeneration.[22] Therefore,
practical methods for the regeneration of coenzyme 1,4-
NADH, the reduced form of nicotinamide adenine dinucle-
otide (NAD+), are still of significant importance in the field
of biocatalysis.
Conversion of NAD+ to NADH by enzymatic,[23–26]
photo- or electrochemical[27–29] methods has been exten-
sively studied in order to increase the rate of cofactor regen-
eration while maintaining the necessary 1,4-dihydro regiose-
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formate as the hydrogen source. When this NADH-regener-
ating catalytic system is combined with NADH-dependent
enzymes, it is possible to chemoenzymatically reduce prochi-
ral ketones such as acetophenone or 4-phenylbutan-2-one
with high enantioselectivity. Combination of horse liver
alcohol dehydrogenase (HLADH) or alcohol dehydrogenase
from Rhodococcus sp. (S-ADH) with 1/formate as the NADH-
regenerating system resulted in ee values up to 98%, de-
pending on the nature of the substrate and the enzyme. In
order to explain the different catalytic activities, the electro-
chemical behaviour of complexes 1–5 has been studied.
lectivity. More than ten years ago Steckhan et al. intro-
duced the dicationic (aqua)(bipyridine)rhodium complex
[(η5-C5Me5)Rh(bipy)(OH2)]2+ as a catalyst for the regenera-
tion of NADH by using the formate anion as the hydrogen
source in aqueous solution.[30,31] In a pioneering paper,
Fishpp et al. extensively studied kinetic and mechanistic de-
tails of regioselective catalytic reduction by using a variety
of 3-pyridinium NAD+ models in the presence of [(η5-
C5Me5)Rh(bipy)(OH2)]2+.[32–35] This NADH-regenerating
catalytic system was applied to the coupled chemoenzym-
atic enantioselective transfer hydrogenation of ketones in
aqueous solution by combining NADH regeneration by an
organorhodium complex and enantioselective ketone re-
duction performed by an alcohol dehydrogenase (ADH).
Steckhan et al. described the transfer hydrogenation of 4-
phenylbutan-2-one to the corresponding alcohol using
ADH from horse liver with enantiomeric excesses up to
96%.[22] More recently, Schmid et al. reported a system
based on ADH from Thermus sp. coupled with [(η5-C5Me5)
Rh(bipy)(OH2)]2+-promoted regeneration of NADH, which
allowed the reduction of 3-methylcyclohexanone with an
enantiomeric excess up to 97%.[1]
In this paper we report a series of water-soluble rhodium,
iridium and ruthenium complexes containing 1,10-phenan-
throline or its 5-substituted analogues as chelating N,N-do-
nor ligands and the catalytic potential of these complexes
for the regeneration of NADH in the chemoenzymatic re-
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duction of ketones. The electrochemical behaviour of the
complexes is also discussed.
Results and Discussion
Synthesis of Phenanthroline Complexes
Complexes [(η5-C5Me5)MCl2]2 (M = Rh, Ir) react at
room temperature in dichloromethane solution with 1,10-
phenanthroline (phen) or with its 5-nitro or 5-amino deriva-
tives to afford quantitatively the cationic complexes [(η5-
C5Me5)M(NN)Cl]+ (1: M = Rh, NN = phen; 2: M =
Rh, NN = 5-NO2-phen; 3: M = Rh, NN = 5-NH2-
phen; and 4: M = Ir, NN = 5-NO2-phen) [Equation (1)].
These cations are easily isolated as their chloride salts.
½[(η5-C5Me5)MCl2]2 + NN [(η5-C5Me5)Rh(NN)Cl]+ + Cl–
(1)
The chloride salts of 1–4 are yellow-orange solids that
have a high solubility in water, a property that is used to
remove unreacted starting material after the synthesis. As
there is a risk of slow hydrolysis in water, the aqueous solu-
tions are immediately filtered, and the filtrates are concen-
trated to dryness to give the analytically pure salts [1–4]Cl.
All compounds have been characterised by 1H and 13C
NMR spectroscopy, mass spectroscopy and elemental
analysis.
In all cases, the phenanthroline ligand is coordinated in
the N,N-chelating fashion to the metal centre. In contrast
to the known, symmetrical 1,10-phenanthroline complex
Scheme 1. Transfer hydrogenation of NAD+ to NADH in aqueous solution catalysed by cationic chlorido complexes 1 to 5 by using the
formate anion as the hydrogen source.
1,[36] the new 5-nitro- and 5-amino-1,10-phenanthroline cat-
ions 2, 3 and 4 are chiral, and compounds [2]Cl, [3]Cl and
[4]Cl are produced as racemic mixtures.
Catalytic Reduction of NAD+ to NADH in Aqueous
Solution
Inspired by the pioneering studies of Steckhan[30] and
Fish[33] on the use of (η5-cyclopentadienyl)rhodium bipyr-
idine complexes as catalysts for the regioselective reduction
of NAD+ models with the formate anion as the hydrogen
source in aqueous solution, we studied this reaction cata-
lysed by cations 1–4 as well as by the previously described
complex [(η6-C6Me6)Ru(5-NO2-phen)Cl]+ (5),[37] which is
known to be active for the reduction of ketones in water
(Scheme 1).
Cations 1–5 were found to promote the reduction of
NAD+ to NADH in aqueous solution with sodium formate
as the hydrogen donor (Table 1). The best results were ob-
tained with rhodium complexes 1–3, which led to TOFs
ranging from 1500 to 2000 h–1 at 60 °C and pH = 7. In
comparison with the analogous bipy complex [(η5-C5Me5)-
Rh(bipy)Cl]+ (TOF = 875 h–1), commonly used as a catalyst
for this reaction, phen analogue 1 is more than twice as
active (TOF = 2000 h–1) under the same conditions.
Ruthenium complex 5 shows a catalytic activity fifteen
times lower than that observed with the related rhodium
complex 2 (entries 6 and 21). The low activity of the ruthe-
nium complex observed in this study is similar to the results
recently published by Sadler et al. describing the use of
(arene)(ethylenediamine)ruthenium complexes for the re-
duction of NAD+ to NADH in aqueous solution at 37 °C
2
Table 1. Transfer hydrogenation of NAD+ to NADH in aqueous solution by using the formate anion as the hydrogen source.[a]
Entry Catalyst ns/nc[b] T[°C] pH Conversion [%] TOF [h–1][c,d]
(Time [h])[c]
1 1 1000 38 7 100 (2.5) 560
2 1000 60 7 100 (0.5) 2000
3 2 15 25 7 100 (3) 19.5
4 15 38 7 100 (0.25) 30
5 50 38 7 100 (0.5) 100
6 100 38 7 100 (2.5) 150
7 500 38 7 100 (3.5) 380
8 1000 38 7 100 (4) 400
9 1000 60 7 100 (0.75) 1740
10 15 38 4[e] 100 (0.5) 29
11 3 1000 38 7 100 (4) 400
12 1000 60 7 100 (1) 1500
13 4 15 25 7 100 (5) 14.4
14 15 38 7 100 (2.5) 23
15 50 38 7 100 (4.5) 47
16 100 38 7 100 (7) 58
17 15 38 4[e] 100 (3) 22.5
18 5 15 25 7 35 (24) 1.5
19 15 38 7 70 (24) 6
20 50 38 7 50 (24) 8
21 100 38 7 20 (24) 10
22 15 38 4[e] 55 (24) 5.4
23 [(η5-C5Me5)Rh(bipy)Cl]+ 1000 60 7 100 (2) 875
[a] Conditions: [NAD+] = 8 mm, [NaHCO2] = 350 mm; reactions carried out in 1 mL of phosphate buffer (pH 7). [b] Mol of substrate
per mol of catalyst. [c] Determined by UV-absorption at 340 nm. [d] Turnover frequencies determined after 30 minutes and expressed in
mol of product/(mol of metal·h). [e] Reactions carried out in phthalate buffer.
Scheme 2. Postulated catalytic cycle, based on the work of Fish, for
the reduction of NAD+ to NADH in aqueous solution with 1 as
the catalyst.
and pH = 7.2.[38] Iridium complex 4 is also two times less
active than the rhodium analogue 2 under the same condi-
tions (entries 6 and 16). The results with varied pH demon-
strate that the catalytic activity does not show any signifi-
cant pH dependence.
According to the mechanistic scheme proposed by Fish
et al. for the analogous bipy complexes,[33] cationic complex
1 is supposed to react with the formate anion to afford the
corresponding hydrido complex, which can reduce NAD+
to NADH (Scheme 2). The postulated catalytic cycle in-
volves a transition state for hydride transfer from the rho-
dium centre to the pyridinium group, in which the NAD+
and the metal hydride form a kinetically stable six-mem-
bered ring.
Electrochemical Behaviour of the Phenanthroline Complexes
The electrochemical behaviour of complexes 1–4 has
been studied by cyclic voltammetry at a stationary platinum
disc and by voltammetry at a rotating platinum disc elec-
trode (RDE) by using acetonitrile solutions (analyte con-
centration: ca. 510–4 m) containing Bu4N[PF6] (0.1 m) as
the supporting electrolyte. Relevant data together with the
parameters for the related Ru complexes[39] are summarised
in Table 2.[40]
The redox response of phenanthroline complex 1 is
shown in Figure 1. The first reduction occurs as a two-elec-
tron irreversible process (up to 500 mVs–1), which is, how-
ever, fast and diffusion controlled (ipa  ν1/2, ilim  ω1/2).
The associated oxidative peak (B) retains the diffusion con-
trol (ip  ν1/2) but shows a peak current lower than that
of the corresponding reduction wave (A). Such behaviour
parallels that of the related cations [LnMCl(bipy)]+ [LnM =
(η5-C5Me5)Rh, (η5-C5Me5)Ir and (η6-arene)Ru; bipy =
3
Table 2. Summary of the electrochemical data.[a]
Compound Ep[V] Reference
[(η5-C5Me5)RhCl(phen)]+ (1) –1.32 (A), –1.10 (B), this work
≈ +0.64 (C)
[(η5-C5Me5)RhCl(5-NO2-phen)]+ (2) –1.01/–0.93 (NO2),[b] this work
–1.43 (A), ≈ +0.64 (C)
[(η5-C5Me5)RhCl(5-NH2-phen)]+ (3) –1.28 (A), –1.16 (B) this work
[(η5-C5Me5)IrCl(phen)]+ (4) –0.99 (A), –0.90 (B), this work
≈ +0.64 (C)
[(η6-C6Me6)RuCl(phen)]+ (5) –1.59 (A) [39]
[(η6-C6Me6)RuCl(5-NO2-phen)]+ –0.99 (E° for NO2) [39]
[(η6-C6Me6)RuCl(5-NH2-phen)]+ –1.58 (A) [39]
[a] The potentials are given relative to the ferrocene/ferrocenium
reference (see the Experimental Section for details). Peak potentials
for irreversible processes were obtained at a scan rate of 100 mVs–1.
Definitions: E° = ½(Epa + Epc), ΔEp = Epa – Epc. [b] Epc/Epa for
the reversible reduction of the nitro group.
2,2-bipyridine] and [(η5-C5Me5)MCl(bpym)]+ (M = Rh
and Ir; bipym = 2,2-bipyrimidine)[41–43] and can be ex-
plained by reductive removal of the chlorido ligand as
shown in Equation (2).
[(η5-C5Me5)M(phen)Cl]+ + 2e–  [(η5-C5Me5)M(phen)] + Cl– (2)
Figure 1. Cyclic voltammogram of 1 as recorded at a platinum disc
electrode in acetonitrile solution at 100 mVs–1 scan rate. The poten-
tials are given relative to the ferrocene/ferrocenium reference.
The neutral electrogenerated species [(η5-C5Me5)-
M(phen)] is probably rather unstable and becomes oxidised
in a single step, giving rise to wave B. A broad wave (C),
observed in the anodic region, can be attributed to oxi-
dation of some decomposition product(s). However, the ex-
act nature of this redox process remains unclear.
The presence of an amino group at the phenanthroline
ligand in 3 has only a minor influence on the electrochemi-
cal behaviour, manifested mainly by a slight shift of the A
and B waves to higher potentials and also by a diminished
A–B separation. On the contrary, substitution with a nitro
group markedly changes the redox response, as the nitro
group is reduced first in a reversible, one-electron process
(–NO2 + e– i –NO2–·), the potential of which is indepen-
dent of the metal (Rh vs. Ir). Such an “inserted” redox step
naturally influences the following one(s).
In the case of 2, the metal-centred reduction occurs at
–1.44 V (wave A), while for 5 only a broad wave at around
–1.6 V could be detected. The associated counterwave (if
any) is difficult to detect. This could explain the higher ac-
tivity of rhodium catalyst 2 as compared with that found for
ruthenium catalyst 5 in the reduction of NAD+ to NADH
described above, the more difficult-to-reduce species being
less catalytically active.
Chemoenzymatic Enantioselective Reduction of Ketones
In light of the findings by Steckhan[22] and Schmid[1] on
organometallic NADH regeneration for enzymatic ketone
reductions, we studied the chemoenzymatic enantioselective
transfer hydrogenation of 4-phenylbutan-2-one and aceto-
phenone in aqueous solution. We used the NADH-depend-
ent enzymes horse liver alcohol dehydrogenase (HLADH)
or alcohol dehydrogenase from Rhodococcus sp. (S-ADH)
and 1 as the NADH-regenerating catalyst with the formate
anion as the hydrogen source (Scheme 3).
Scheme 3. Organometallic NADH regeneration for the stereoselec-
tive reduction of ketones with alcohol dehydrogenase.
The NADH-regenerating catalytic system with 1 as the
catalyst was found to be active in combination with the two
enzymes used (HLADH and S-ADH) for the enantioselec-
tive reduction of the test substrates (Table 3). The reaction
proceeds with good to excellent enantioselectivity, produc-
ing predominantly the S enantiomer.
The results show the enantioselectivities to be similar to
those found without the organometallic NADH regenera-
tion catalyst with ee values up to 92 and 98%. However,
the enzymatic activity with NADH regeneration is some-
what lower relative to enzymatic ketone reduction with ex-
cess NADH. This could be explained by a deactivation of
the organometallic catalyst during the reaction, probably
due to coordination of functional enzyme groups to the
rhodium centre.
The mechanistic aspects of the combined organometal-
lic–enzymatic catalysis are summarised in Scheme 4, which
is a combination of Scheme 2 and Scheme 3. The organo-
metallic intermediates [(η5-C5Me5)Rh(phenanthroline)H]+
and [(η5-C5Me5)Rh(phenanthroline)(OH2)]2+ work hand-
in-hand with the coenzyme intermediates NAD+ and
NADH to perform the enantioselective reduction of a
ketone to give the corresponding alcohol, with aqueous so-
dium formate as hydrogen source and a dehydrogenase en-
zyme as chiral inducer.
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Table 3. Chemoenzymatic enantioselective transfer hydrogenation of ketones with alcohol dehydrogenase and 1 as NADH-regenerating
catalysts in aqueous solution.[a]
Conc. of RhEntry Ketone Enzyme t [h] Conversion [%][b] ee [%][b][mm]
1[c] 4-phenylbutan-2-one HLADH 0 24 80 96
2[d] 4-phenylbutan-2-one none 0.5 24 4 n.d.
3 4-phenylbutan-2-one HLADH 0.5 24 62 92
4 4-phenylbutan-2-one HLADH 0.1 24 47 88
5 4-phenylbutan-2-one HLADH 0.01 24 1.2 n.d.
6 4-phenylbutan-2-one HLADH 0.002 24 0.5 n.d.
7 acetophenone HLADH 0.5 24 2 n.d.
8[c] acetophenone S-ADH 0 24 78 98
9[d] acetophenone none 0.5 24 8 n.d.
10 acetophenone S-ADH 0.5 24 58 74
11 acetophenone S-ADH 0.1 24 20 98
[a] Conditions: [NAD+] = 1 mm, [NaHCO2] = 100 mm, [ketone] = 33 mm, reactions carried out with 1 unit of alcohol dehydrogenase in
1 mL of phosphate buffer (pH 7) at 37 °C. [b] Determined by chiral HPLC analysis. [c] Conditions: [NADH] = 40 mm, [NaHCO2] =
100 mm, [ketone] = 33 mm, reactions carried out with 1 unit of alcohol dehydrogenase in 1 mL of phosphate buffer (pH 7) at 37 °C. [d]
Reaction carried out without HLADH or S-ADH and NAD+.
Scheme 4. Catalytic cycle for the chemoenzymatic enantioselective transfer hydrogenation of ketones with 1 as NADH regenerating
catalyst in aqueous solution.
Conclusions
In conclusion, we report here a series of five water-solu-
ble rhodium, iridium and ruthenium complexes containing
1,10-phenanthroline and derivatives thereof as chelating li-
gands. All these complexes were found to catalyse the 1,4-
regioselective reduction of NAD+ to NADH in aqueous
solution. TOF values up to 2000 h–1 have been obtained by
using [(η5-C5Me5)Rh(phen)Cl]+ (1) as a catalyst at 60 °C
and pH = 7. Furthermore, rhodium catalyst 1 has been
found to be active as an NADH-regenerating catalyst for
the chemoenzymatic enantioselective transfer hydrogena-
tion of ketones in aqueous solution. Under biological con-
ditions (37 °C, pH = 7), this system, which combines orga-
nometallic NADH regeneration and enzymatic reduction in
aqueous solution, converts ketones into the corresponding
chiral alcohols with good activities and enantioselectivities.
Experimental Section
General: All manipulations were carried out with freshly distilled
solvents. The 5-amino-1,10-phenanthroline[44] and [(η6-C6Me6)-
Ru(5-NO2-phen)Cl]+ (5)[37] were prepared according to the pub-
lished methods. All other reagents were commercially available and
were used without further purification. NMR spectra were re-
corded with a Bruker 400 MHz spectrometer by using sodium 2,2-
dimethyl-2-silapentane-5-sulfonate in D2O as an internal standard.
Electrospray mass spectra were obtained in the positive-ion mode
with an LCQ Finnigan mass spectrometer. Microanalyses were car-
ried out by the Laboratoire de Chimie Pharmaceutique, Université
de Genève (Switzerland).
Electrochemical measurements were carried out with a multipur-
pose polarograph PA3 interfaced to a Model 4103 XY recorder
(Laboratorní prˇístroje, Prague) at room temperature by using a
standard three-electrode cell with a rotating platinum disc electrode
(RDE; 1 mm diameter) as the working electrode, platinum wire as
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the auxiliary electrode and a saturated calomel electrode (SCE) as
the reference electrode. The reference electrode was separated from
the analysed solution by a salt bridge (0.1 m Bu4N[PF6] in acetoni-
trile). The samples were dissolved in acetonitrile (Riedel-de Haën,
purissimum p.a.), to give an analyte concentration of 510–4 m,
and in 0.1 m Bu4N[PF6] (Fluka, purissimum for electrochemistry).
The solutions were purged with argon prior to the measurement
and then kept under an argon blanket. Cyclic voltammograms were
recorded at a stationary platinum disc electrode (scan rates 50–
500 mV/s), while the voltammograms were obtained at a RDE
(1000–2500 rpm, scan rate 20 mV/s). The redox potentials are given
relative to the ferrocene/ferrocenium reference.
Preparation of Chlorido Complexes [(η5-C5Me5)M(NN)Cl]+ (M =
Rh, Ir and NN = phen, 5-NO2-phen, 5-NH2-phen): Two equiva-
lents (0.30 mmol) of the appropriate phenanthroline donor were
added to a suspension of [(η5-C5Me5)MCl2]2 (M = Rh, Ir;
0.15 mmol) in dichloromethane (30 mL). The mixture was stirred
for 3 h at room temperature, while the colour changed from dark
orange to yellow-orange. After concentration to dryness, the resi-
due was dissolved in water. This solution was filtered, and the fil-
trate was concentrated to dryness, which gave the product as a yel-
low powder in good yield.
[(η5-C5Me5)Rh(phen)Cl]Cl ([1]Cl): Yield: 74%, 80.8 mg. 1H NMR
(400 MHz, D2O, 21 °C): δ = 1.70 (s, CH3), 7.99 (s, CH), 8.05–8.12
(dd, 3JH,H = 5.1 Hz, 3JH,H = 8.1 Hz, CH), 8.67–8.71 (d, 3JH,H =
8.1 Hz, CH), 9.28–9.31 (d, 3JH,H = 5.1 Hz, CH) ppm. 13C NMR
(200 MHz, D2O, 21 °C): δ = 8.32 [C5(CH3)5], 97.9 [C5(CH3)5],
126.63 (CH), 127.62 (CH), 130.98 (CH), 139.47 (CH), 146.08 (C),
155.62 (C) ppm. MS (ESI): m/z = 453 [M]+. C22H23Cl2N2Rh
(489.24): calcd. C 54.01, H 4.74, N 5.73; found C 53.91, H 4.82, N
5.68.
[(η5-C5Me5)Rh(NO2-phen)Cl]Cl ([2]Cl): Yield: 85%, 85.4 mg. 1H
NMR (400 MHz, D2O, 21 °C): δ = 1.68 (s, CH3), 7.99 (s, CH),
8.16–8.21 (quint, 3JH,H = 4.5 Hz, CH), 8.83–8.85 (d, 3JH,H =
8.2 Hz, CH), 8.96 (s, CH), 9.19–9.22 (d, 3JH,H = 8.7 Hz, CH), 9.36
(d, 3JH,H = 4.7 Hz, CH), 9.41 (d, 3JH,H = 4.8 Hz, CH) ppm. 13C
NMR (200 MHz, D2O, 21 °C): δ = 8.52 [C5(CH3)5], 98.8 [C5(CH3)
5], 123.62 (C), 127.63 (CH), 127.81 (C), 128.38 (CH), 128.41 (CH),
136.51 (CH), 141.71 (CH), 144.31 (C), 145.72 (C), 146.98 (C),
153.44 (CH), 155.14 (CH) ppm. MS (ESI): m/z = 498 [M+].
C22H22Cl2N3O2Rh (534.24): calcd. C 49.46, H 4.15, N 7.87; found
C 49.32, H 4.18, N 7.63.
[(η5-C5Me5)Rh(NH2-phen)Cl]Cl ([3]Cl): Yield: 80%, 78.7 mg. 1H
NMR (400 MHz, D2O, 21 °C): δ = 1.64 (s, CH3), 6.60 (s, CH),
7.72–7.79 (dd, 3JH,H = 5.4 Hz, 3JH,H = 8.7 Hz, CH), 7.96–8.07 (m,
3JH,H = 8.8 Hz, CH), 8.54–8.58 (d, 3JH,H = 8.4 Hz, CH), 8.88–8.90
(d, 3JH,H = 4.4 Hz, CH), 9.22–9.24 (d, 3JH,H = 4.1 Hz, CH) ppm.
13C NMR (200 MHz, D2O, 21 °C): δ = 8.47 [C5(CH3)5], 97.9
[C5(CH3)5], 107.56 (CH), 126.52 (C), 126.80 (CH), 128.02 (CH),
128.91 (CH), 134.49 (CH), 136.00 (C), 138.41 (C), 145.54 (C),
148.94 (C), 151.81 (CH), 155.71 (CH) ppm. MS (ESI): m/z = 468
[M]+. C22H24Cl2N3Rh (504.26): calcd. C 52.40, H 4.80, N 8.33;
found C 52.18, H 4.92, N 8.16.
[(η5-C5Me5)Ir(NO2-phen)Cl]Cl ([4]Cl): Yield: 84%, 81.2 mg. 1H
NMR (400 MHz, D2O, 21 °C): δ = 1.53 (s, CH3), 8.05–8.09 (dd,
3JH,H = 5.3 Hz, 3JH,H = 8.8 Hz, CH), 8.94 (s, CH), 9.08–9.11 (d,
3JH,H = 8.7 Hz, CH), 9.22 (d, 3JH,H = 5.2 Hz, CH), 9.27 (d, 3JH,H
= 5.4 Hz, CH) ppm. 13C NMR (200 MHz, D2O, 21 °C): δ = 8.14
[C5(CH3)5], 90.72 [C5(CH3)5], 124.02 (C), 127.75 (CH), 128.02 (C),
128.76 (CH), 128.83 (CH), 136.59 (CH), 141.64 (CH), 144.53 (C),
147.14 (C), 148.28 (C), 153.17 (CH), 154.76 (CH) ppm. MS (ESI):
m/z = 588 [M]+. C22H22Cl2IrN3O2 (623.55): calcd. C 42.38, H 3.56,
N 6.74; found C 42.24, H 3.67, N 6.54.
Catalytic NADH Regeneration: The reduction of NAD+ (8 mm) ca-
talysed by complexes [1–5]Cl with sodium formate (350 mm) as the
hydrogen source was carried out in phosphate buffer (1 mL, pH 7)
or in phthalate buffer (1 mL, pH 4). The conversion was deter-
mined by UV absorption at 340 nm. The pH was monitored with
a pH meter (Mettler Toledo InLab® 413). Turnover frequencies
were calculated for all the catalytic reactions from the conversions
observed after 30 min for the hydrogenation reaction of NAD+ to
NADH. The results are summarised in Table 1.
Chemoenzymatic Hydrogenation of Ketones: The enzymatic transfer
hydrogenation reactions of acetophenone or 4-phenylbutan-2-one
(33 mm) were carried out in phosphate buffer (1 mL, pH 7) at 37 °C
with 1 unit of alcohol dehydrogenase S-ADH or HLADH respec-
tively, in the presence of NAD+ (1 mm) and [1]Cl as NADH-regen-
erating catalyst and NaHCO2 (100 mm) as the hydrogen source.
The reactions without rhodium catalyst were performed with
NADH instead of NAD+ (40 mm), and the reactions without enzy-
matic reduction were performed without enzyme and NAD+. The
products were extracted with diethyl ether, filtered through silica
and identified (and conversion and enantiomeric excess were deter-
mined) by HPLC on a Chiracel OD-H capillary column (hexane/
2-propanol 9:10, 0.7 mLmin–1, 215 nm). The pH was monitored
with a pH meter (Mettler Toledo InLab® 413).
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